Interventions for Preventing Thromboembolic Events in Patients With Atrial Fibrillation-Reference-Cited by-同舟云学术

Interventions for Preventing Thromboembolic Events in Patients With Atrial Fibrillation

Published:2018-10-30 Issue:11 Volume:169 Page:774
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Lowenstern Angela¹,Al-Khatib Sana M.¹,Sharan Lauren¹,Chatterjee Ranee¹,Allen LaPointe Nancy M.²,Shah Bimal³,Borre Ethan D.¹,Raitz Giselle¹,Goode Adam¹,Yapa Roshini⁴,Davis J. Kelly⁵,Lallinger Kathryn¹,Schmidt Robyn¹,Kosinski Andrzej S.¹,Sanders Gillian D.⁶

Affiliation:

1. Duke University School of Medicine, Durham, North Carolina (A.L., S.M.A., L.S., R.C., E.D.B., G.R., A.G., K.L., R.S., A.S.K.)

2. Duke University School of Medicine, Durham, and Premier, Charlotte, North Carolina (N.M.A.)

3. Duke University School of Medicine, Durham, North Carolina, and Livongo, Mountain View, California (B.S.)

4. University of Colorado, Aurora, Colorado (R.Y.)

5. Duke University, Durham, North Carolina (J.K.D.)

6. Duke University School of Medicine and Duke University, Durham, North Carolina (G.D.S.)

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Comprehensive Review;Cureus;2024-07-25

2. Comparative effectiveness and safety of apixaban and rivaroxaban in older patients with atrial fibrillation: A population-based cohort study;Heart Rhythm;2024-06

3. Serious Bleeding in Patients With Atrial Fibrillation Using Diltiazem With Apixaban or Rivaroxaban;JAMA;2024-05-14

4. Predictors of adherence to direct oral anticoagulants after cardiovascular or bleeding events in Medicare Advantage Plan enrollees with atrial fibrillation;Journal of Managed Care & Specialty Pharmacy;2024-05

5. Risk for Bleeding-Related Hospitalizations During Use of Amiodarone With Apixaban or Rivaroxaban in Patients With Atrial Fibrillation;Annals of Internal Medicine;2023-06